Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, P.O. Box: 19395-4763, Tehran, I.R. Iran.
J Endocrinol Invest. 2012 May;35(5):516-21. doi: 10.3275/7968. Epub 2011 Sep 30.
Despite the high prevalence of thyroid dysfunction, the epidemiology and natural course of these disorders have not been identified yet.
The present survey was conducted to determine the incidence of thyroid dysfunction and natural course of subclinical thyroid disorders in an urban community of Tehran, I.R. Iran.
Serum TSH and thyroperoxidase antibody (TPOAb) were measured at baseline and after 6.7 yr from a sample of 1999 randomly selected subjects aged≥20 yr, participants of the Tehran Lipid and Glucose Study (TLGS). Median TSH value and 2.5, 5, 95, and 97.5 TSH percentiles were determined at baseline using data obtained from 808 negative TPOAb subjects with no history of any thyroid disease or surgery, goiter, nodule, taking thyroid hormone preparations or anti-thyroid drugs. In those with abnormal TSH level, total T4 and T3 uptake were measured and free T4 index was calculated.
Normal TSH reference range was 0.4-5.8 μU/ml according to the 2.5 and 97.5 TSH percentiles. The incidence rates of thyroid function abnormalities in 1000 subjects per year were as follows: clinical hypothyroidism: 0.28 in women and 0.21 in men; subclinical hypothyroidism: 11.59 in women and 4.69 in men; clinical hyperthyroidism: 1.4 in women and 0.21 in men; and subclinical hyperthyroidism: 5.72 in women and 3.62 in men. A significant increase was found in the frequency of positive TPOAb in women from 15.9 to 17.7% (p=0.006). Of 8 women with subclinical hypothyroidism at baseline, 5 remained unchanged, 1 became normal, and 1 developed clinical hypothyroidism at followup. Two women with subclinical hyperthyroidism normalized at follow-up. Of 2 men with subclinical hypothyroidism at baseline, 1 remained unchanged, whereas the other progressed to clinical hypothyroidism.
After a 6.7 yr follow-up significant increase in the incidence of subclinical thyroid disorders was observed in both men and women, as compared to overt thyroid dysfunction. Increase in the prevalence of TPOAb positivity was observed only in women.
尽管甲状腺功能障碍的患病率很高,但这些疾病的流行病学和自然病程尚未确定。
本研究旨在确定伊朗德黑兰市一个城区甲状腺功能障碍的发生率以及亚临床甲状腺疾病的自然病程。
采用随机抽样的方法,从参加德黑兰血脂和血糖研究(TLGS)的 1999 名年龄≥20 岁的受试者中选取 1999 名受试者,检测其血清促甲状腺激素(TSH)和甲状腺过氧化物酶抗体(TPOAb)水平。采用 808 例无甲状腺疾病或手术史、甲状腺肿、结节、服用甲状腺激素制剂或抗甲状腺药物史、阴性 TPOAb 受试者的基线数据,确定中位 TSH 值和 2.5、5、95、97.5 TSH 百分位数。对 TSH 水平异常的患者,检测总 T4 和 T3 摄取率,并计算游离 T4 指数。
根据 2.5 和 97.5 TSH 百分位数,正常 TSH 参考范围为 0.4-5.8μU/ml。每年每 1000 例患者甲状腺功能异常的发生率如下:临床甲状腺功能减退症:女性为 0.28,男性为 0.21;亚临床甲状腺功能减退症:女性为 11.59,男性为 4.69;临床甲状腺功能亢进症:女性为 1.4,男性为 0.21;亚临床甲状腺功能亢进症:女性为 5.72,男性为 3.62。女性 TPOAb 阳性率从 15.9%升至 17.7%(p=0.006)。8 例基线亚临床甲状腺功能减退症患者中,5 例无变化,1 例转为正常,1 例随访时发展为临床甲状腺功能减退症。2 例亚临床甲状腺功能亢进症患者随访时恢复正常。2 例基线亚临床甲状腺功能减退症患者中,1 例无变化,另 1 例进展为临床甲状腺功能减退症。
与显性甲状腺功能障碍相比,6.7 年后男性和女性亚临床甲状腺疾病的发生率显著增加。仅观察到 TPOAb 阳性率增加,且仅见于女性。